Supplementary Figure 17 from Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma

Key Points

• Significant differences in fecal metabolite levels were observed between multiple myeloma patients and healthy donors.
• The data indicates mean metabolite abundance with standard deviation for multiple metabolites analyzed via Mann-Whitney test.
• This analysis provides insights into metabolic alterations associated with CAR-T therapy outcomes in patients.
• Findings are crucial for understanding the metabolic influences on immune responses during cancer treatments.